Analysis of Antifungal Activity of Bacillus spp.

碩士 === 大葉大學 === 分子生物科技學系碩士班 === 94 === The object of this study is to examine 34 clinical isolates of Bacillus spp. from blood of pseudo bacteremia patients in Linkou Chang Gung Memorial Hospital, focusing on species classification, antifungal activity, and identification of antifungal gene and acti...

Full description

Bibliographic Details
Main Authors: Ji Yun Lin, 林芷妘
Other Authors: Shu Ying Liu
Format: Others
Language:zh-TW
Published: 2006
Online Access:http://ndltd.ncl.edu.tw/handle/48654771474332917415
id ndltd-TW-094DYU00061006
record_format oai_dc
spelling ndltd-TW-094DYU000610062015-10-13T10:38:06Z http://ndltd.ncl.edu.tw/handle/48654771474332917415 Analysis of Antifungal Activity of Bacillus spp. 桿菌屬臨床分離菌株抗真菌作用之分析 Ji Yun Lin 林芷妘 碩士 大葉大學 分子生物科技學系碩士班 94 The object of this study is to examine 34 clinical isolates of Bacillus spp. from blood of pseudo bacteremia patients in Linkou Chang Gung Memorial Hospital, focusing on species classification, antifungal activity, and identification of antifungal gene and active components. Bacterial classification was based on phenotyping (catalase test, reduction of nitrate, hemolysis test, indole production test, citrate utilization test, urease test, Voges-Proskauer test) and genotyping (polymerase chain reaction). All 34 clinical isolates of Bacillus spp. belonged to 8 species: B. cereus, B. thuringiensis, B. coagulans, B. licheniformis, B. pumilus, B. megaterium, B. circulans and B. firmus. From the results of antifungal analysis, B. thuringiensis CG 2, B. thuringiensis CG 4, B. pumilus CG 12, B. cereus CG 15, B. cereus CG 20 and B. cereus CG 26 exhibited significant antifungal activities. These six isolates were further analysed for their antifungal mechanism on Paecilomyces variotii Tü137. It’s well known that Bacillus subtilis F29-3 produces one antibiotic--fengycin, which effectively inhibits the growth of filamentous fungi. According to the sequence of fenB, 3 PCR primer sets were designed to analyze whether any of these 34 clinical isolates of Bacillus spp. contained fenB gene of fengycin. With one primer set, a 1.0 Kb fragment can be amplified in all 6 isolates with antifungal activity. The sequence of the PCR product showed high homology to ilvD. Whether ilvD is related to the antifungal activity remained to be elucidated. Furthermore, to identify the active components contributing to the antifungal activity, the fermentation supernatant were obtained from 6 isolates with antifungal activity and B. subtilis F29-3. After filtration, the supernatants showed no antifungal activity to Paecilomyces variotii Tü137. It appeared that only viable bacteria expressed antifungal activity. Shu Ying Liu Cheng Hsun Chiu 劉淑瑛 邱政洵 2006 學位論文 ; thesis 86 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 大葉大學 === 分子生物科技學系碩士班 === 94 === The object of this study is to examine 34 clinical isolates of Bacillus spp. from blood of pseudo bacteremia patients in Linkou Chang Gung Memorial Hospital, focusing on species classification, antifungal activity, and identification of antifungal gene and active components. Bacterial classification was based on phenotyping (catalase test, reduction of nitrate, hemolysis test, indole production test, citrate utilization test, urease test, Voges-Proskauer test) and genotyping (polymerase chain reaction). All 34 clinical isolates of Bacillus spp. belonged to 8 species: B. cereus, B. thuringiensis, B. coagulans, B. licheniformis, B. pumilus, B. megaterium, B. circulans and B. firmus. From the results of antifungal analysis, B. thuringiensis CG 2, B. thuringiensis CG 4, B. pumilus CG 12, B. cereus CG 15, B. cereus CG 20 and B. cereus CG 26 exhibited significant antifungal activities. These six isolates were further analysed for their antifungal mechanism on Paecilomyces variotii Tü137. It’s well known that Bacillus subtilis F29-3 produces one antibiotic--fengycin, which effectively inhibits the growth of filamentous fungi. According to the sequence of fenB, 3 PCR primer sets were designed to analyze whether any of these 34 clinical isolates of Bacillus spp. contained fenB gene of fengycin. With one primer set, a 1.0 Kb fragment can be amplified in all 6 isolates with antifungal activity. The sequence of the PCR product showed high homology to ilvD. Whether ilvD is related to the antifungal activity remained to be elucidated. Furthermore, to identify the active components contributing to the antifungal activity, the fermentation supernatant were obtained from 6 isolates with antifungal activity and B. subtilis F29-3. After filtration, the supernatants showed no antifungal activity to Paecilomyces variotii Tü137. It appeared that only viable bacteria expressed antifungal activity.
author2 Shu Ying Liu
author_facet Shu Ying Liu
Ji Yun Lin
林芷妘
author Ji Yun Lin
林芷妘
spellingShingle Ji Yun Lin
林芷妘
Analysis of Antifungal Activity of Bacillus spp.
author_sort Ji Yun Lin
title Analysis of Antifungal Activity of Bacillus spp.
title_short Analysis of Antifungal Activity of Bacillus spp.
title_full Analysis of Antifungal Activity of Bacillus spp.
title_fullStr Analysis of Antifungal Activity of Bacillus spp.
title_full_unstemmed Analysis of Antifungal Activity of Bacillus spp.
title_sort analysis of antifungal activity of bacillus spp.
publishDate 2006
url http://ndltd.ncl.edu.tw/handle/48654771474332917415
work_keys_str_mv AT jiyunlin analysisofantifungalactivityofbacillusspp
AT línzhǐyún analysisofantifungalactivityofbacillusspp
AT jiyunlin gǎnjūnshǔlínchuángfēnlíjūnzhūkàngzhēnjūnzuòyòngzhīfēnxī
AT línzhǐyún gǎnjūnshǔlínchuángfēnlíjūnzhūkàngzhēnjūnzuòyòngzhīfēnxī
_version_ 1716831336216395776